Veradigm (NASDAQ:MDRX) Trading Up 14.9% – Time to Buy?

Shares of Veradigm Inc. (NASDAQ:MDRX) traded up 14.9% on Friday . The company traded as high as $5.00 and last traded at $5.00. 819 shares were traded during trading, a decline of 100% from the average session volume of 242,356 shares. The stock had previously closed at $4.35.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded Veradigm to a “hold” rating in a report on Saturday, March 7th.

Veradigm Stock Up 9.2%

The firm has a market capitalization of $517.28 million, a price-to-earnings ratio of 23.25 and a beta of 0.54. The company’s fifty day moving average is $4.61 and its two-hundred day moving average is $4.71.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.